Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ALLAY

ACETAMINOPHEN; HYDROCODONE BITARTRATE

Standard Dose
500MG;5MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview ALLAY is listed in Drugs@FDA under application 089907 (ANDA).

Marketing status: Discontinued Active ingredient ACETAMINOPHEN; HYDROCODONE BITARTRATE Form and strength CAPSULE;ORAL - 500MG;5MG Sponsor IVAX PHARMS Submission history Latest submission status date: 1997-05-05 00:00:00.

Structured Monograph

Clinical summary

Approval overview ALLAY is listed in Drugs@FDA under application 089907 (ANDA). Marketing status: Discontinued Active ingredient ACETAMINOPHEN; HYDROCODONE BITARTRATE Form and strength CAPSULE;ORAL - 500MG;5MG Sponsor IVAX PHARMS Submission history Latest submission status date: 1997-05-05 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.